Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes

Purpose: In the treatment of type 2 diabetes mellitus (T2DM), select sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are recommended based on comorbidities such as chronic kidney disease (CKD), heart failure (HF), and atherosclerotic cardiovasc...

Full description

Saved in:
Bibliographic Details
Main Authors: Bethany Murphy, Simran Chahal, Elleigh Shepherd, Nicole Taylor, Austin Camp
Format: Article
Language:English
Published: University of Minnesota Libraries Publishing 2025-01-01
Series:INNOVATIONS in Pharmacy
Subjects:
transitions of care
GLP-1 receptor agonists
SGLT2 inhibitors
diabetes
Online Access:https://pubs.lib.umn.edu/index.php/innovations/article/view/6432
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items